1. Home
  2. GOCO vs XLO Comparison

GOCO vs XLO Comparison

Compare GOCO & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.57

Market Cap

38.3M

Sector

Finance

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.53

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
XLO
Founded
2001
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
39.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GOCO
XLO
Price
$1.57
$0.53
Analyst Decision
Hold
Buy
Analyst Count
2
1
Target Price
$5.00
$2.00
AVG Volume (30 Days)
34.1K
478.3K
Earning Date
01-01-0001
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
90.82
60.79
EPS
N/A
N/A
Revenue
$798,894,000.00
$6,344,000.00
Revenue This Year
N/A
$626.78
Revenue Next Year
N/A
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
8.74
N/A
52 Week Low
$1.31
$0.50
52 Week High
$16.40
$1.18

Technical Indicators

Market Signals
Indicator
GOCO
XLO
Relative Strength Index (RSI) 40.08 37.47
Support Level N/A $0.50
Resistance Level $2.56 $0.74
Average True Range (ATR) 0.13 0.04
MACD -0.00 0.00
Stochastic Oscillator 37.14 26.85

Price Performance

Historical Comparison
GOCO
XLO

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: